These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16020671)

  • 21. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
    Chen X; Zhang M; Liu LX
    Oncol Rep; 2009 Jul; 22(1):73-80. PubMed ID: 19513507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
    Chen J; Cheng J; Yi J; Xie B; Lin L; Liu Z; Zhao H; Wang B; Ai Z; Yang Y; Wei H
    Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression.
    Li X; Ding X; Adrian TE
    Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
    Jung HS; Kim HS; Lee MJ; Shin HY; Ahn HS; Ryu KH; Seoh JY; Kim CJ; Jang JJ
    FEBS Lett; 2006 Sep; 580(20):4969-75. PubMed ID: 16930595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide overcomes apoptosis inhibition in K562/ADM cells by regulating vital components in apoptotic pathway.
    Wang DH; Wei HL; Zhao HS; Hao CY; Min ZH; Liu JM
    Pharmacol Res; 2005 Nov; 52(5):376-85. PubMed ID: 15979894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis.
    Siu KP; Chan JY; Fung KP
    Life Sci; 2002 Jun; 71(3):275-85. PubMed ID: 12034346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
    Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
    J Natl Cancer Inst; 2004 Oct; 96(19):1457-66. PubMed ID: 15467035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
    Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3.
    Jiang XH; Wong BC; Yuen ST; Jiang SH; Cho CH; Lai KC; Lin MC; Kung HF; Lam SK
    Int J Cancer; 2001 Jan; 91(2):173-9. PubMed ID: 11146441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
    Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
    Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells.
    Cheung WM; Chu PW; Kwong YL
    Cancer Lett; 2007 Feb; 246(1-2):122-8. PubMed ID: 16569477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells.
    Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X
    J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma.
    Tung JN; Cheng YW; Hsu CH; Liu TZ; Hsieh PY; Ting LL; Ko HL; Chang YJ; Chiou JF; Wu AT
    Ann Surg Oncol; 2011 May; 18(5):1492-500. PubMed ID: 21181559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells.
    Bakhshaiesh TO; Armat M; Shanehbandi D; Sharifi S; Baradaran B; Hejazi MS; Samadi N
    Asian Pac J Cancer Prev; 2015; 16(13):5191-7. PubMed ID: 26225652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
    Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
    Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin L silencing increases As
    Primon M; Huszthy PC; Motaln H; Talasila KM; Miletic H; Atai NA; Bjerkvig R; Lah Turnšek T
    Exp Cell Res; 2017 Jul; 356(1):64-73. PubMed ID: 28412241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
    La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
    Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.